Spots Global Cancer Trial Database for cancer stem cells
Every month we try and update this database with for cancer stem cells cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer | NCT03632798 | Recurrent Ovari... | ChemoID assay Chemotherapy | 18 Years - | Cordgenics, LLC | |
| Feasibility Study on Stem Cells Sensitivity Assay | NCT01483001 | Lung Cancer Colorectal Canc... Breast Cancer | Cancer Stem Cel... | 18 Years - | Associazione Oncologia Traslazionale | |
| Vacuolar ATPase and Drug Resistance of High Grade Gliomas | NCT05328089 | Glioblastoma Mu... | 18 Years - 90 Years | University of Milano Bicocca | ||
| Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer | NCT01951690 | Non Small Cell ... Lung Cancer | defactinib (VS-... | 18 Years - | Verastem, Inc. | |
| Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies | NCT01849744 | Non Hematologic... Metastatic Canc... | VS-4718 | 18 Years - | Verastem, Inc. | |
| Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma | NCT02010606 | Glioblastoma Glioblastoma Mu... Glioma Astrocytoma Brain Tumor | Dendritic cell ... Dendritic cell ... | 18 Years - | Cedars-Sinai Medical Center | |
| Feasibility Study on Stem Cells Sensitivity Assay | NCT01483001 | Lung Cancer Colorectal Canc... Breast Cancer | Cancer Stem Cel... | 18 Years - | Associazione Oncologia Traslazionale | |
| Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma | NCT02010606 | Glioblastoma Glioblastoma Mu... Glioma Astrocytoma Brain Tumor | Dendritic cell ... Dendritic cell ... | 18 Years - | Cedars-Sinai Medical Center | |
| Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology | NCT02727673 | Cancer Stem Cel... Postoperative R... Hepatocellular ... | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | ||
| The Natural History of Solid Organ Cancer Stem Cells (SOCSC) | NCT00923052 | Hepatic Cancer Pancreatic Duct... Colorectal Canc... Breast Cancer Gastric Cancer | 16 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies | NCT01943292 | Non Hematologic... | Defactinib | 20 Years - | Verastem, Inc. | |
| Vacuolar ATPase and Drug Resistance of High Grade Gliomas | NCT05328089 | Glioblastoma Mu... | 18 Years - 90 Years | University of Milano Bicocca | ||
| Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System | NCT04817501 | Breast Cancer Ovarian Cancer Endometrial Can... | Taking 5 ml of ... Taking 5 ml EDT... | 18 Years - 80 Years | Tomsk National Research Medical Center of the Russian Academy of Sciences | |
| Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System | NCT04817501 | Breast Cancer Ovarian Cancer Endometrial Can... | Taking 5 ml of ... Taking 5 ml EDT... | 18 Years - 80 Years | Tomsk National Research Medical Center of the Russian Academy of Sciences | |
| Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma | NCT03632135 | Recurrent Gliob... | ChemoID assay Chemotherapy | 18 Years - | Cordgenics, LLC | |
| Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies | NCT01849744 | Non Hematologic... Metastatic Canc... | VS-4718 | 18 Years - | Verastem, Inc. | |
| An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer | NCT03505528 | Metastatic Brea... | Nanoparticle al... Phenelzine Sulf... | 18 Years - | EpiAxis Therapeutics | |
| Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma | NCT03632135 | Recurrent Gliob... | ChemoID assay Chemotherapy | 18 Years - | Cordgenics, LLC | |
| Isolation and Characterization of Mammary Stem Cells | NCT00340392 | Stem Cells | - | National Institutes of Health Clinical Center (CC) | ||
| Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial] | NCT01879878 | Pancreatic Duct... | Verum, broccoli... placebo | 18 Years - | Heidelberg University | |
| Feasibility Study on Stem Cells Sensitivity Assay | NCT01483001 | Lung Cancer Colorectal Canc... Breast Cancer | Cancer Stem Cel... | 18 Years - | Associazione Oncologia Traslazionale | |
| Vacuolar ATPase and Drug Resistance of High Grade Gliomas | NCT05328089 | Glioblastoma Mu... | 18 Years - 90 Years | University of Milano Bicocca | ||
| Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer | NCT02775695 | Resectable Panc... | Doxycycline | 18 Years - | Medical College of Wisconsin | |
| Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer | NCT02775695 | Resectable Panc... | Doxycycline | 18 Years - | Medical College of Wisconsin | |
| A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer | NCT02370238 | Metastatic Brea... | paclitaxel Reparixin placebo | 18 Years - | Dompé Farmaceutici S.p.A | |
| Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours | NCT04907422 | Carcinoma Ex Pl... Pleomorphic Ade... | CD24-Gold Nanoc... non-conjugated ... | - | October 6 University | |
| A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer | NCT02370238 | Metastatic Brea... | paclitaxel Reparixin placebo | 18 Years - | Dompé Farmaceutici S.p.A | |
| Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer | NCT03949283 | Recurrent Ovari... Platinum-resist... | ChemoID Assay Standard Chemot... | 18 Years - | Cordgenics, LLC | |
| Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours | NCT04907422 | Carcinoma Ex Pl... Pleomorphic Ade... | CD24-Gold Nanoc... non-conjugated ... | - | October 6 University | |
| The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas | NCT00473408 | Anaplastic Astr... Glioblastoma Mu... Tumor Angiogene... | Functional MRI ... Blood sample Tumor sample | 18 Years - | Haukeland University Hospital | |
| Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness | NCT06348693 | Glioblastoma Glioma Glioma Glioblas... | cell isolation ... | 18 Years - | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
| A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer | NCT02370238 | Metastatic Brea... | paclitaxel Reparixin placebo | 18 Years - | Dompé Farmaceutici S.p.A | |
| GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers | NCT01118975 | Breast Cancer Neoplasm Metast... | Vorinostat Lapatinib | 18 Years - | University of Maryland, Baltimore | |
| Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies | NCT01943292 | Non Hematologic... | Defactinib | 20 Years - | Verastem, Inc. | |
| Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells (RepriM) | NCT02570100 | Breast Cancer | Biological coll... | 18 Years - | Centre Oscar Lambret | |
| An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer | NCT03505528 | Metastatic Brea... | Nanoparticle al... Phenelzine Sulf... | 18 Years - | EpiAxis Therapeutics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
